1 Study Coverage 1.1 Acute Bronchitis Treatment Product Introduction 1.2 Global Acute Bronchitis Treatment Outlook 2017 VS 2022 VS 2028 1.2.1 Global Acute Bronchitis Treatment Sales in US$ Million for the Year 2017-2028 1.2.2 Global Acute Bronchitis Treatment Sales in Volume for the Year 2017-2028 1.3 United States Acute Bronchitis Treatment Outlook 2017 VS 2022 VS 2028 1.3.1 United States Acute Bronchitis Treatment Sales in US$ Million for the Year 2017-2028 1.3.2 United States Acute Bronchitis Treatment Sales in Volume for the Year 2017-2028 1.4 Acute Bronchitis Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Acute Bronchitis Treatment in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Acute Bronchitis Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Acute Bronchitis Treatment Market Dynamics 1.5.1 Acute Bronchitis Treatment Industry Trends 1.5.2 Acute Bronchitis Treatment Market Drivers 1.5.3 Acute Bronchitis Treatment Market Challenges 1.5.4 Acute Bronchitis Treatment Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Acute Bronchitis Treatment Market Segment by Type 2.1.1 Antibiotics 2.1.2 Anti-inflammatory Drugs 2.1.3 Bronchodilator 2.1.4 Mucolytics 2.2 Global Acute Bronchitis Treatment Market Size by Type 2.2.1 Global Acute Bronchitis Treatment Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Acute Bronchitis Treatment Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Acute Bronchitis Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Acute Bronchitis Treatment Market Size by Type 2.3.1 United States Acute Bronchitis Treatment Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Acute Bronchitis Treatment Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Acute Bronchitis Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Acute Bronchitis Treatment Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Retail Pharmacies 3.1.3 Online Pharmacies 3.2 Global Acute Bronchitis Treatment Market Size by Application 3.2.1 Global Acute Bronchitis Treatment Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Acute Bronchitis Treatment Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Acute Bronchitis Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Acute Bronchitis Treatment Market Size by Application 3.3.1 United States Acute Bronchitis Treatment Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Acute Bronchitis Treatment Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Acute Bronchitis Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Acute Bronchitis Treatment Competitor Landscape by Company 4.1 Global Acute Bronchitis Treatment Market Size by Company 4.1.1 Top Global Acute Bronchitis Treatment Manufacturers Ranked by Revenue (2021) 4.1.2 Global Acute Bronchitis Treatment Revenue by Manufacturer (2017-2022) 4.1.3 Global Acute Bronchitis Treatment Sales by Manufacturer (2017-2022) 4.1.4 Global Acute Bronchitis Treatment Price by Manufacturer (2017-2022) 4.2 Global Acute Bronchitis Treatment Concentration Ratio (CR) 4.2.1 Acute Bronchitis Treatment Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Acute Bronchitis Treatment in 2021 4.2.3 Global Acute Bronchitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Acute Bronchitis Treatment Manufacturing Base Distribution, Product Type 4.3.1 Global Acute Bronchitis Treatment Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Acute Bronchitis Treatment Product Type 4.3.3 Date of International Manufacturers Enter into Acute Bronchitis Treatment Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Acute Bronchitis Treatment Market Size by Company 4.5.1 Top Acute Bronchitis Treatment Players in United States, Ranked by Revenue (2021) 4.5.2 United States Acute Bronchitis Treatment Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Acute Bronchitis Treatment Sales by Players (2020, 2021 & 2022) 5 Global Acute Bronchitis Treatment Market Size by Region 5.1 Global Acute Bronchitis Treatment Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Acute Bronchitis Treatment Market Size in Volume by Region (2017-2028) 5.2.1 Global Acute Bronchitis Treatment Sales in Volume by Region: 2017-2022 5.2.2 Global Acute Bronchitis Treatment Sales in Volume Forecast by Region (2023-2028) 5.3 Global Acute Bronchitis Treatment Market Size in Value by Region (2017-2028) 5.3.1 Global Acute Bronchitis Treatment Sales in Value by Region: 2017-2022 5.3.2 Global Acute Bronchitis Treatment Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Acute Bronchitis Treatment Market Size YoY Growth 2017-2028 6.1.2 North America Acute Bronchitis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Acute Bronchitis Treatment Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Acute Bronchitis Treatment Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Acute Bronchitis Treatment Market Size YoY Growth 2017-2028 6.3.2 Europe Acute Bronchitis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Acute Bronchitis Treatment Market Size YoY Growth 2017-2028 6.4.2 Latin America Acute Bronchitis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Acute Bronchitis Treatment Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Acute Bronchitis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 AstraZeneca 7.1.1 AstraZeneca Corporation Information 7.1.2 AstraZeneca Description and Business Overview 7.1.3 AstraZeneca Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.1.4 AstraZeneca Acute Bronchitis Treatment Products Offered 7.1.5 AstraZeneca Recent Development 7.2 Boehringer Ingelheim International 7.2.1 Boehringer Ingelheim International Corporation Information 7.2.2 Boehringer Ingelheim International Description and Business Overview 7.2.3 Boehringer Ingelheim International Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Boehringer Ingelheim International Acute Bronchitis Treatment Products Offered 7.2.5 Boehringer Ingelheim International Recent Development 7.3 GlaxoSmithKline 7.3.1 GlaxoSmithKline Corporation Information 7.3.2 GlaxoSmithKline Description and Business Overview 7.3.3 GlaxoSmithKline Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.3.4 GlaxoSmithKline Acute Bronchitis Treatment Products Offered 7.3.5 GlaxoSmithKline Recent Development 7.4 Novartis AG 7.4.1 Novartis AG Corporation Information 7.4.2 Novartis AG Description and Business Overview 7.4.3 Novartis AG Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Novartis AG Acute Bronchitis Treatment Products Offered 7.4.5 Novartis AG Recent Development 7.5 Melinta Therapeutics 7.5.1 Melinta Therapeutics Corporation Information 7.5.2 Melinta Therapeutics Description and Business Overview 7.5.3 Melinta Therapeutics Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Melinta Therapeutics Acute Bronchitis Treatment Products Offered 7.5.5 Melinta Therapeutics Recent Development 7.6 Dr Reddy's Laboratories 7.6.1 Dr Reddy's Laboratories Corporation Information 7.6.2 Dr Reddy's Laboratories Description and Business Overview 7.6.3 Dr Reddy's Laboratories Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Dr Reddy's Laboratories Acute Bronchitis Treatment Products Offered 7.6.5 Dr Reddy's Laboratories Recent Development 7.7 Sanofi 7.7.1 Sanofi Corporation Information 7.7.2 Sanofi Description and Business Overview 7.7.3 Sanofi Acute Bronchitis Treatment Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Sanofi Acute Bronchitis Treatment Products Offered 7.7.5 Sanofi Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Acute Bronchitis Treatment Industry Chain Analysis 8.2 Acute Bronchitis Treatment Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Acute Bronchitis Treatment Distributors 8.3 Acute Bronchitis Treatment Production Mode & Process 8.4 Acute Bronchitis Treatment Sales and Marketing 8.4.1 Acute Bronchitis Treatment Sales Channels 8.4.2 Acute Bronchitis Treatment Distributors 8.5 Acute Bronchitis Treatment Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Acute Bronchitis Treatment CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Acute Bronchitis Treatment Market Trends Table 3. Acute Bronchitis Treatment Market Drivers Table 4. Acute Bronchitis Treatment Market Challenges Table 5. Acute Bronchitis Treatment Market Restraints Table 6. Global Acute Bronchitis Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Acute Bronchitis Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Acute Bronchitis Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Acute Bronchitis Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Acute Bronchitis Treatment Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Acute Bronchitis Treatment Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Acute Bronchitis Treatment Revenue Share by Manufacturer, 2017-2022 Table 13. Global Acute Bronchitis Treatment Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Acute Bronchitis Treatment Sales Share by Manufacturer, 2017-2022 Table 15. Global Acute Bronchitis Treatment Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Acute Bronchitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Acute Bronchitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Bronchitis Treatment as of 2021) Table 18. Top Players of Acute Bronchitis Treatment in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Acute Bronchitis Treatment Product Type Table 20. Date of International Manufacturers Enter into Acute Bronchitis Treatment Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Acute Bronchitis Treatment Players in United States Market, Ranking by Revenue (2021) Table 23. United States Acute Bronchitis Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Acute Bronchitis Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Acute Bronchitis Treatment Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Acute Bronchitis Treatment Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Acute Bronchitis Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Acute Bronchitis Treatment Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Acute Bronchitis Treatment Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Acute Bronchitis Treatment Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Acute Bronchitis Treatment Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Acute Bronchitis Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Acute Bronchitis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Acute Bronchitis Treatment Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Acute Bronchitis Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Acute Bronchitis Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Acute Bronchitis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Acute Bronchitis Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Acute Bronchitis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Acute Bronchitis Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Acute Bronchitis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 42. AstraZeneca Corporation Information Table 43. AstraZeneca Description and Business Overview Table 44. AstraZeneca Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. AstraZeneca Acute Bronchitis Treatment Product Table 46. AstraZeneca Recent Development Table 47. Boehringer Ingelheim International Corporation Information Table 48. Boehringer Ingelheim International Description and Business Overview Table 49. Boehringer Ingelheim International Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Boehringer Ingelheim International Product Table 51. Boehringer Ingelheim International Recent Development Table 52. GlaxoSmithKline Corporation Information Table 53. GlaxoSmithKline Description and Business Overview Table 54. GlaxoSmithKline Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. GlaxoSmithKline Product Table 56. GlaxoSmithKline Recent Development Table 57. Novartis AG Corporation Information Table 58. Novartis AG Description and Business Overview Table 59. Novartis AG Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Novartis AG Product Table 61. Novartis AG Recent Development Table 62. Melinta Therapeutics Corporation Information Table 63. Melinta Therapeutics Description and Business Overview Table 64. Melinta Therapeutics Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Melinta Therapeutics Product Table 66. Melinta Therapeutics Recent Development Table 67. Dr Reddy's Laboratories Corporation Information Table 68. Dr Reddy's Laboratories Description and Business Overview Table 69. Dr Reddy's Laboratories Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Dr Reddy's Laboratories Product Table 71. Dr Reddy's Laboratories Recent Development Table 72. Sanofi Corporation Information Table 73. Sanofi Description and Business Overview Table 74. Sanofi Acute Bronchitis Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Sanofi Product Table 76. Sanofi Recent Development Table 77. Key Raw Materials Lists Table 78. Raw Materials Key Suppliers Lists Table 79. Acute Bronchitis Treatment Customers List Table 80. Acute Bronchitis Treatment Distributors List Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Acute Bronchitis Treatment Product Picture Figure 2. Global Acute Bronchitis Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Acute Bronchitis Treatment Market Size 2017-2028 (US$ Million) Figure 4. Global Acute Bronchitis Treatment Sales 2017-2028 (K Units) Figure 5. United States Acute Bronchitis Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Acute Bronchitis Treatment Market Size 2017-2028 (US$ Million) Figure 7. United States Acute Bronchitis Treatment Sales 2017-2028 (K Units) Figure 8. United States Acute Bronchitis Treatment Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Acute Bronchitis Treatment Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Acute Bronchitis Treatment Report Years Considered Figure 11. Product Picture of Antibiotics Figure 12. Product Picture of Anti-inflammatory Drugs Figure 13. Product Picture of Bronchodilator Figure 14. Product Picture of Mucolytics Figure 15. Global Acute Bronchitis Treatment Market Share by Type in 2022 & 2028 Figure 16. Global Acute Bronchitis Treatment Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Acute Bronchitis Treatment Sales Market Share in Value by Type (2017-2028) Figure 18. Global Acute Bronchitis Treatment Sales by Type (2017-2028) & (K Units) Figure 19. Global Acute Bronchitis Treatment Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Acute Bronchitis Treatment Price by Type (2017-2028) & (USD/Unit) Figure 21. United States Acute Bronchitis Treatment Market Share by Type in 2022 & 2028 Figure 22. United States Acute Bronchitis Treatment Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Acute Bronchitis Treatment Sales Market Share in Value by Type (2017-2028) Figure 24. United States Acute Bronchitis Treatment Sales by Type (2017-2028) & (K Units) Figure 25. United States Acute Bronchitis Treatment Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Acute Bronchitis Treatment Price by Type (2017-2028) & (USD/Unit) Figure 27. Product Picture of Hospital Pharmacies Figure 28. Product Picture of Retail Pharmacies Figure 29. Product Picture of Online Pharmacies Figure 30. Global Acute Bronchitis Treatment Market Share by Application in 2022 & 2028 Figure 31. Global Acute Bronchitis Treatment Sales in Value by Application (2017-2028) & (US$ Million) Figure 32. Global Acute Bronchitis Treatment Sales Market Share in Value by Application (2017-2028) Figure 33. Global Acute Bronchitis Treatment Sales by Application (2017-2028) & (K Units) Figure 34. Global Acute Bronchitis Treatment Sales Market Share in Volume by Application (2017-2028) Figure 35. Global Acute Bronchitis Treatment Price by Application (2017-2028) & (USD/Unit) Figure 36. United States Acute Bronchitis Treatment Market Share by Application in 2022 & 2028 Figure 37. United States Acute Bronchitis Treatment Sales in Value by Application (2017-2028) & (US$ Million) Figure 38. United States Acute Bronchitis Treatment Sales Market Share in Value by Application (2017-2028) Figure 39. United States Acute Bronchitis Treatment Sales by Application (2017-2028) & (K Units) Figure 40. United States Acute Bronchitis Treatment Sales Market Share in Volume by Application (2017-2028) Figure 41. United States Acute Bronchitis Treatment Price by Application (2017-2028) & (USD/Unit) Figure 42. North America Acute Bronchitis Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 43. North America Acute Bronchitis Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 44. U.S. Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Canada Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Europe Acute Bronchitis Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 47. Europe Acute Bronchitis Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 48. Germany Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. France Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. U.K. Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Italy Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Russia Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Asia-Pacific Acute Bronchitis Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 54. Asia-Pacific Acute Bronchitis Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 55. China Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Japan Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. South Korea Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. India Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Australia Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Taiwan Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Indonesia Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Thailand Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Malaysia Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Philippines Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Latin America Acute Bronchitis Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 66. Latin America Acute Bronchitis Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 67. Mexico Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Brazil Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Argentina Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Middle East & Africa Acute Bronchitis Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 71. Middle East & Africa Acute Bronchitis Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 72. Turkey Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Saudi Arabia Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. U.A.E Acute Bronchitis Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. Acute Bronchitis Treatment Value Chain Figure 76. Acute Bronchitis Treatment Production Process Figure 77. Channels of Distribution Figure 78. Distributors Profiles Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

AstraZeneca Boehringer Ingelheim International GlaxoSmithKline Novartis AG Melinta Therapeutics Dr Reddy's Laboratories Sanofi